WIA
BIOA

Wealthedge Investment Advisors’s BioAge Labs BIOA Stock Holding History

Wealthedge Investment Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,585
Closed -$61.3K – 216
2024
Q4 		$61.3K Buy
+10,585
New +$183K 0.03% 169

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Wealthedge Investment Advisors's BIOA Position: Q1 2025 in Review

Wealthedge Investment Advisors sold out of BioAge Labs (BIOA) in Q1 2025, closing a stake of 10,585 shares — an estimated $61.3K sold.

Wealthedge Investment Advisors first reported a position in BIOA in Q4 2024 and held it in 1 quarter. The position peaked at $61.3K in Q4 2024. 67 funds tracked by Wall St. Rank hold BIOA as of Q1 2025.

  • Wealthedge Investment Advisors reported no remaining BioAge Labs position as of Q1 2025 after selling out during the quarter.
  • Wealthedge Investment Advisors sold 10,585 BioAge Labs shares in Q1 2025, an estimated $61.3K.
  • Wealthedge Investment Advisors first reported a position in BioAge Labs in Q4 2024 and held it in 1 quarter.
  • Wealthedge Investment Advisors's BioAge Labs position peaked at $61.3K in Q4 2024.
  • 67 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2025.

Based on Wealthedge Investment Advisors's 13F filing for Q1 2025, filed 13 May 2025.